Creative Planning’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-128,976
| Closed | -$778K | – | 2176 |
|
|
2019
Q4 | $778K | Hold |
128,976
| – | – | ﹤0.01% | 903 |
|
|
2019
Q3 | $464K | Hold |
128,976
| – | – | ﹤0.01% | 1113 |
|
|
2019
Q2 | $346K | Hold |
128,976
| – | – | ﹤0.01% | 1284 |
|
|
2019
Q1 | $382K | Buy |
128,976
+13,500
| +12% | +$33.2K | ﹤0.01% | 1194 |
|
|
2018
Q4 | $184K | Sell |
115,476
-4,000
| -3% | -$11.3K | ﹤0.01% | 1522 |
|
|
2018
Q3 | $440K | Hold |
119,476
| – | – | ﹤0.01% | 1159 |
|
|
2018
Q2 | $338K | Hold |
119,476
| – | – | ﹤0.01% | 1299 |
|
|
2018
Q1 | $443K | Sell |
119,476
-9,700
| -8% | -$31.7K | ﹤0.01% | 1139 |
|
|
2017
Q4 | $372K | Sell |
129,176
-26,900
| -17% | -$97.7K | ﹤0.01% | 1246 |
|
|
2017
Q3 | $701K | Buy |
156,076
+246
| +0.2% | +$1.09K | ﹤0.01% | 883 |
|
|
2017
Q2 | $715K | Buy |
155,830
+254
| +0.2% | +$1.02K | ﹤0.01% | 841 |
|
|
2017
Q1 | $655K | Buy |
155,576
+3,000
| +2% | +$12.5K | ﹤0.01% | 842 |
|
|
2016
Q4 | $630K | Sell |
152,576
-4,875
| -3% | -$25.9K | ﹤0.01% | 815 |
|
|
2016
Q3 | $1.27M | Buy |
157,451
+24,276
| +18% | +$206K | 0.01% | 511 |
|
|
2016
Q2 | $1.04M | Buy |
133,175
+1,000
| +0.8% | +$8.58K | 0.01% | 511 |
|
|
2016
Q1 | $1.02M | Buy |
132,175
+74,475
| +129% | +$545K | 0.01% | 500 |
|
|
2015
Q4 | $623K | Buy |
57,700
+20,500
| +55% | +$186K | 0.01% | 665 |
|
|
2015
Q3 | $257K | Buy |
37,200
+5,230
| +16% | +$42.6K | ﹤0.01% | 1049 |
|
|
2015
Q2 | $283K | Sell |
31,970
-2,439
| -7% | -$23.1K | ﹤0.01% | 809 |
|
|
2015
Q1 | $339K | Buy |
34,409
+11,309
| +49% | +$141K | ﹤0.01% | 934 |
|
|
2014
Q4 | $283K | Sell |
23,100
-28,900
| -56% | -$353K | ﹤0.01% | 970 |
|
|
2014
Q3 | $519K | Buy |
52,000
+42,000
| +420% | +$390K | 0.01% | 640 |
|
|
2014
Q2 | $76K | Sell |
10,000
-4,470
| -31% | -$17.8K | ﹤0.01% | 1611 |
|
|
2014
Q1 | $48K | Hold |
14,470
| – | – | ﹤0.01% | 1829 |
|
|
2013
Q4 | $48K | Buy |
14,470
+10,000
| +224% | +$29K | ﹤0.01% | 1637 |
|
|
2013
Q3 | $13K | Buy |
+4,470
| New | +$30.6K | ﹤0.01% | 2333 |
|
Creative Planning's ACHN Position: Q1 2020 in Review
Creative Planning sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 128,976 shares — an estimated $778K sold.
Creative Planning first reported a position in ACHN in Q3 2013 and held it in 26 quarters. The position peaked at $1.27M in Q3 2016. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Creative Planning reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Creative Planning sold 128,976 Achillion Pharmaceuticals shares in Q1 2020, an estimated $778K.
- Creative Planning first reported a position in Achillion Pharmaceuticals in Q3 2013 and held it in 26 quarters.
- Creative Planning's Achillion Pharmaceuticals position peaked at $1.27M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Creative Planning's 13F filing for Q1 2020, filed 5 May 2020.